Samarth Kulkarni, Ph.D.
Chief Executive Officer, CRISPR Therapeutics
Thursday, Nov. 15, 2018 • 4:15 PM–5:30 PM
Dr. Samarth Kulkarni is CEO and a member of the Board of Directors at CRISPR Therapeutics. He joined CRISPR in the early stages of the company and was responsible for setting corporate strategy, supporting financing and establishing partnerships with Bayer and Vertex. Dr. Kulkarni was previously a Partner at McKinsey and Company, where he held a leading role in the Pharmaceutical and Medical products practice. Dr. Kulkarni also serves as a member of the Casebia Board of Directors.
Dr. Kulkarni received his Ph.D. in bioengineering and nanotechnology from the University of Washington and a B. Tech. from the Indian Institute of Technology.